No Data
No Data
Two Up, One Down: ASX Healthcare Stocks Split After FY24 Results
Neuren Pharmaceuticals Ltd: H1 2024 financial results
Neuren Pharmaceuticals Ltd: Half Yearly Report and Accounts
Ten-baggers Galore! These 19 Top ASX Stocks Returned 1,000% or More in Just 10 Years
These ASX Shares Could Rise 20% to 60%
Neuren Pharmaceuticals Target Price Cut 6.5% to A$29.00/Share by Canaccord Genuity>NEU.AU
No Data
No Data